MENU
VRTX
AS OF
Dec 24 closing price
Price
$462.99
Change
+$3.78 (+0.82%)
Capitalization
117.47B
41 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
VRTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Vertex Pharmaceuticals (VRTX) Ownership - Who owns Vertex Pharmaceuticals?

Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
50 Northern Avenue
Phone
+1 617 341-6100
Employees
5400
Web
https://www.vrtx.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
117.47B
P/E Ratio
32.58
Total Cash
6.29B
Projected Growth
2.74
Total Debt
1.83B
Revenue
11.72B
Risk (Beta)
0.63
Dividend Yield
N/A
Total Cash/Share
24.78
Total Debt/Equity
43.97
Revenue/Share
45.39 USD as % of share price

Fundamentals

VRTX
Capitalization
117B
P/E Ratio
32.58
Risk (Beta)
0.63
Dividend Yield
N/A
Total Cash
6.29B
Total Cash/Share
24.78
Total Debt
1.84B
Total Debt/Equity
43.97
Projected Growth (PEG Ratio)
2.74
Revenue/Share (as % of the share price)
45.39%
Revenue
11.7B
ROE
N/A
Book Value
17.3B
P/B Ratio
6.78
Cash Flow
N/A
Earnings
14.3
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
2.5M
Current Ratio
2.36
Current Revenue Per Employee
504327.88
Dividends Per Share - Security
N/A
EBITDA
4.66B
Float
N/A
Float - Current
N/A
Gross Income Margin
86.52
Revenue To Assets
15.60
Shares Held By Institutions
357B
Shares Outstanding - Current
254M
Total Liabilities
7.54B
Total Volume MTD
N/A
Value
-1
Gain YTD
14.971
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
VRTX
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. VRTX showed earnings on November 03, 2025. You can read more about the earnings report here.
View AI-Driven Trading for VRTX
A.I. Advisor
published General Information

General Information

a company that discovers and develops novel, small molecule pharmaceuticals

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
50 Northern Avenue
Phone
+1 617 341-6100
Employees
5400
Web
https://www.vrtx.com